Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Förster-Ruhrmann

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
HNO|April 10, 2024
[Importance of aspirin challenges in patients with NSAID-exacerbated respiratory disease]Ulrike Förster-Ruhrmann, Heidi Olze
The Journal of Allergy and Clinical Immunology|May 18, 2020
COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumabUlrike Förster-Ruhrmann, Agnieszka J Szczepek, Claus Bachert, et al.
The Laryngoscope|April 15, 2016
Impact of cochlear implantation on quality of life and mental comorbidity in patients aged 80 yearsSteffen Knopke, Stefan Gräbel, Ulrike Förster-Ruhrmann, et al.
Allergologie Select|January 4, 2021
Can nasal acetylsalicylic acid challenge predict the severity of non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (N-ERD)?
Ulrike Förster-Ruhrmann, Anne-Kristin Tietz, Jonghui Kim, et al.
The World Allergy Organization Journal|February 28, 2023
A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologicsUlrike Förster-Ruhrmann, Dafni Stergioudi, Agnieszka J Szczepek, et al.
Journal of Personalized Medicine|April 23, 2022
Chemokine Expression-Based Endotype Clustering of Chronic RhinosinusitisUlrike Förster-Ruhrmann, Agnieszka J Szczepek, Greta Pierchalla, et al.
Allergy|August 7, 2024
Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 yearsPatrick Huber, Ulrike Förster-Ruhrmann, Heidi Olze, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 20, 2021
Analysis of genetic impact on smell impairment in patients with hereditary angioedema type 1 and 2Ulrike Förster-Ruhrmann, Greta Pierchalla, Christiane Stieber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 21, 2021
Untersuchung genetischer Einflüsse auf Riechstörungen bei Patienten mit hereditärem Angioödem Typ 1 und 2Ulrike Förster-Ruhrmann, Greta Pierchalla, Christiane Stieber, et al.
Chinese Medicine|December 19, 2021
Acupressure in patients with seasonal allergic rhinitis: a randomized controlled exploratory trialLukas Israel, Gabriele Rotter, Ulrike Förster-Ruhrmann, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
HNO|April 10, 2024
[Importance of aspirin challenges in patients with NSAID-exacerbated respiratory disease]Ulrike Förster-Ruhrmann, Heidi Olze
The Journal of Allergy and Clinical Immunology|May 18, 2020
COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumabUlrike Förster-Ruhrmann, Agnieszka J Szczepek, Claus Bachert, et al.
The Laryngoscope|April 15, 2016
Impact of cochlear implantation on quality of life and mental comorbidity in patients aged 80 yearsSteffen Knopke, Stefan Gräbel, Ulrike Förster-Ruhrmann, et al.
Allergologie Select|January 4, 2021
Can nasal acetylsalicylic acid challenge predict the severity of non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (N-ERD)?
Ulrike Förster-Ruhrmann, Anne-Kristin Tietz, Jonghui Kim, et al.
The World Allergy Organization Journal|February 28, 2023
A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologicsUlrike Förster-Ruhrmann, Dafni Stergioudi, Agnieszka J Szczepek, et al.
Journal of Personalized Medicine|April 23, 2022
Chemokine Expression-Based Endotype Clustering of Chronic RhinosinusitisUlrike Förster-Ruhrmann, Agnieszka J Szczepek, Greta Pierchalla, et al.
Allergy|August 7, 2024
Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 yearsPatrick Huber, Ulrike Förster-Ruhrmann, Heidi Olze, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 20, 2021
Analysis of genetic impact on smell impairment in patients with hereditary angioedema type 1 and 2Ulrike Förster-Ruhrmann, Greta Pierchalla, Christiane Stieber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 21, 2021
Untersuchung genetischer Einflüsse auf Riechstörungen bei Patienten mit hereditärem Angioödem Typ 1 und 2Ulrike Förster-Ruhrmann, Greta Pierchalla, Christiane Stieber, et al.
Chinese Medicine|December 19, 2021
Acupressure in patients with seasonal allergic rhinitis: a randomized controlled exploratory trialLukas Israel, Gabriele Rotter, Ulrike Förster-Ruhrmann, et al.
Pageof 2